Biotech Values

[exwannabe]

Re: "I’m surprised no one here has commented on a MNTA matter I posted about recently that could turn out to be more consequential to investors than the minutia of the Lovenox launch. Does anyone know what I’m referring to?"

I do not think you are posting about inequitable conduct, as somebody has commented on how that effects MNTA.

I will go with the valuation on the ENDP buyout of ?? deal.